LGR6 and serous adenocarcinoma: In this study, our results reported that LGR6 was differentially upregulated in different histologic types of ovarian cancer, particularly in high-grade serous adenocarcinoma, and high expression of LGR6 positively correlated with histologic types, FIGO stages, poor chemotherapeutic response, and poor progression in ovarian cancer patients.